Ignite Creation Date:
2025-12-24 @ 9:36 PM
Ignite Modification Date:
2026-03-27 @ 9:15 PM
Study NCT ID:
NCT05027932
Status:
COMPLETED
Last Update Posted:
2025-04-08
First Post:
2021-08-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-27
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-25
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-28
First Submit QC Date:
None
Study First Post Date:
2021-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-02-28
Results First Submit QC Date:
None
Results First Post Date:
2025-04-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-21
Last Update Post Date:
2025-04-08
Last Update Post Date Type:
ACTUAL